Synthesis and biological activity of 5-chloro-N4-substituted phenyl-9H-pyrimido[4,5-b]indole-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic agents

This publication has 35 references indexed in Scilit:

• Receptor-Based Virtual Screening of EGFR Kinase Inhibitors from the NCI Diversity Database
  Molecules, 2010
• Single Agents with Designed Combination Chemotherapy Potential: Synthesis and Evaluation of Substituted Pyrimido[4,5-b]indoles as Receptor Tyrosine Kinase and Thymidylate Synthase Inhibitors and as Antitumor Agents
  Journal of Medicinal Chemistry, 2010
• Selectively Nonselective Kinase Inhibition: Striking the Right Balance
  Journal of Medicinal Chemistry, 2009
• Nilotinib
  Clinical Cancer Research, 2008
• The Role of VEGF and EGFR Inhibition: Implications for Combining Anti–VEGF and Anti–EGFR Agents
  Molecular Cancer Research, 2007
• Lapatinib: A novel EGFR/HER2 tyrosine kinase inhibitor for cancer
  Drugs of Today, 2006
• Role of Tyrosine Kinase Inhibitors in Cancer Therapy
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2005
• The discovery of receptor tyrosine kinases: targets for cancer therapy
  Nature Reviews Cancer, 2004
• The biology of VEGF and its receptors
  Nature Medicine, 2003